2McMahan CJ, Slack JL, Mosley B, et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types[J]. EMBO J, 1991, 10(10): 2821-2832.
3Sims JE, Giri JG, Dower SK. The two interleukin-1 Receptors play different roles in IL-1 actions[J]. Clin Immunol Immunopathol, 1994, 72(1): 9-14.
4Martin MU, Wesche H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family[J]. Biochim Biophys Acta, 2002, 1592(3): 265-280.
5Mantovani A, Locati M, Vecchi A, et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines[J]. Trends Immunol, 2001, 22(6): 328-336.
6Liu C, Hart RP, Liu XJ, et al. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA[J]. J Biol Chem, 1996, 271(34): 20965-20972.
7Detlef N, Christian K, Michael U, et al. The membrane form of the type II IL-1 receptor accounts for inhibitory function[J]. J Immunol, 2000, 165(6): 3350-3357.
8Orlando S, Polentarutti N, Mantovani A. Selectivity release of the type II decoy IL-1 receptor[J]. Cytokine, 2000, 12(7): 1001-1006.
9Bresnihan B, Alvaro-Gracia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist[J]. Arthritis Rheum, 1998, 41(12): 2196-2204.
10Fredericks ZL, Forte C, Capuano IV, et al. Identification of potent human anti-IL-1RI antagonist antibodies[J]. Protein Eng Des Sel, 2004, 17(1): 95-106.
